Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning announced that Jad Nammour has joined the company as its new Chief of Pharmacy. Nammour has over 20 years of experience as a pharmacist, as well as a specialized certification in the preparation of magisterial formulas. Nammour’s duties include ensuring that controlled substances and drugs are managed and handled correctly in accordance with regulations. He will also oversee all of the company’s storage and warehousing of any controlled substances. “The addition of Jad Nammour to our team means that the management and development teams are now complete. We have all of the knowledge, experience and proficiency that we need to bring our products to the marketplace and become a licensed distributor of drugs and controlled substances in Canada, as announced earlier this year,” Earth Science Tech CEO & CSO Dr. Michel Aube stated in the news release.
To view the full press release, visit http://ibn.fm/frd00
About Earth Science Tech, Inc.
Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil. For more information, visit the company’s website at www.EarthScienceTech.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
